Showing results (491-500 of 529,926) with videos related to
Sort By:
Pageof 52,993
The Journal of Organic Chemistry|September 22, 2021
Recyclable Gold Catalyst for the Stereoselective Thioallylation of AlkynesWenli Hu, Bingbo Niu, Xiaoqiang Xiao, et al.Molecular Plant|April 13, 2023
FLK is an mRNA m6A reader that regulates floral transition by modulating the stability and splicing of FLC in ArabidopsisUmme Amara, Jianzhong Hu, Jing Cai, et al.Frontiers in Endocrinology|May 18, 2023
Emerging trends in DNA and RNA methylation modifications in type 2 diabetes mellitus: a bibliometric and visual analysis from 1992 to 2022Cai Jiang, Yue Hu, Sinuo Wang, et al.Mitochondrial DNA. Part A, DNA Mapping, Sequencing, and Analysis|January 21, 2014
The complete mitochondrial genome of an assassin bug Peirates arcuatus (Hemiptera: Reduviidae)Guangyu Zhao, Hu Li, Fan Song, et al.Journal of Drug Targeting|January 11, 2014
Experiments and synthesis of bone-targeting epirubicin with the water-soluble macromolecular drug delivery systems of oxidized-dextranLi Yu, Lin Cai, Hao Hu, et al.Frontiers in Public Health|February 6, 2023
Effects of functional limitations and activities of daily living on the mortality of the older people: A cohort study in ChinaYumeng Gao, Liang Du, Jianping Cai, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 21, 2025
Integrating Bulk RNA-Seq and Spatial Transcriptomics Data to Reveal Distinct Immune Escape Mechanism and Immunotherapy Based on Post-Translational Modification in Head and Neck Squamous Cell CarcinomaKai Li, Chuyi Cai, Qingmei Chen, et al.Journal of Cancer Research and Therapeutics|December 26, 2025
Inhibition of MDM2 by nutlin-3 decreased pyroptosis but increased apoptosis of lung carcinoma cells under 5-FU chemotherapyTingting Hu, Hongyi Cai, Xiaoyu Duan, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 10, 2025
Sexual dimorphism of white-matter functional connectome in healthy young adultsZhuo-Yan Cai, Kang Hu, Ze-Qiang LinliFrontiers in Immunology|December 3, 2025
Response to dabrafenib and trametinib combined with pembrolizumab in an elderly patient with lung adenocarcinoma of unknown primary harboring BRAF V600E mutation and high PD-L1 expression: a case reportNan Li, Jing Hu, Guangjin Bao, et al.Pageof 52,993